헬스케어 유통 시장 : 유형별, 최종 용도별 - 세계 예측(2024-2032년)

Global Healthcare Distribution Market will demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure handling and distribution of pharmaceuticals. As patient safety becomes increasingly critical, the demand for reliable, traceable distribution systems rises, fostering trust and reliability in the supply chain. These innovations and safety measures are propelling market expansion, meeting the evolving needs of the healthcare industry, and enhancing overall distribution practices.

For instance, in October 2023, Tecsys introduced its Elite Warehouse Management System (WMS) for Healthcare Distribution, designed to help companies comply with the Drug Supply Chain Security Act (DSCSA) regulations. The introduction of such innovative solutions reflects the industry's response to stringent regulatory requirements and the need for robust, compliant distribution practices, driving market growth and technological innovation.

The healthcare distribution industry is divided based on type, end-use, and region.

The biopharmaceutical product distribution services segment will see a considerable surge by 2032, attributed to the growing demand for complex and specialized therapies. The rise in biologics and personalized medicine requires advanced distribution solutions to ensure the safe and efficient handling of temperature-sensitive products. This segment benefits from stringent regulatory requirements and the need for precise logistics to maintain product efficacy. Increased investment in cold chain infrastructure and specialized distribution networks further supports the dominance of biopharmaceutical distribution services in the market.

The hospital pharmacies segment will garner notable gains by 2032, driven by the critical role these pharmacies play in managing and dispensing medications within healthcare settings. As hospitals expand and healthcare services increase, the demand for efficient, reliable pharmaceutical distribution within these facilities rises. Hospital pharmacies require specialized distribution services to handle a wide range of drugs, including complex and high-cost treatments. Their central role in patient care and the need for precise inventory management drive their dominant position in the market.

Europe healthcare distribution market will secure a moderate CAGR through 2032, owing to its well-established healthcare infrastructure and advanced distribution networks. The region's strong emphasis on regulatory compliance, quality standards, and efficient supply chains supports its dominance. Additionally, Europe's aging population and growing demand for advanced medical products drive the need for robust distribution systems. The integration of technology and innovation in distribution practices further enhances Europe's market position, making it a vital contributor to the global healthcare distribution industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 High incidence and large economic burden of chronic diseases
    • 3.2.1.2 Favorable R&D investment scenario and subsequent increase in drug launches
    • 3.2.1.3 Growth of track and trace solutions
    • 3.2.1.4 Growing adoption of generic drugs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High operational costs
    • 3.2.2.2 Stringent regulatory compliance and changes
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
  • 3.5.3 Asia Pacific
• 3.6 Technological landscape
  • 3.6.1 Core technologies
  • 3.6.2 Adjacent technologies
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Pharmaceutical product distribution services
  • 5.2.1 OTC drugs/vitamins
  • 5.2.2 Generic drugs
  • 5.2.3 Brand-name/innovator drugs
• 5.3 Biopharmaceutical product distribution services
  • 5.3.1 Monoclonal antibodies
  • 5.3.2 Vaccines
  • 5.3.3 Recombinant proteins
  • 5.3.4 Blood and blood products
  • 5.3.5 Other products
• 5.4 Medical device distribution services

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospital pharmacies
• 6.3 Retail pharmacies
• 6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 Alliance Healthcare
• 8.2 AmerisourceBergen Corporation
• 8.3 Anda, Inc.
• 8.4 Cardinal Health, Inc.
• 8.5 Celesio AG
• 8.6 CuraScript SD
• 8.7 Henry Schein, Inc.
• 8.8 McKesson Corporation
• 8.9 Medline Industries, Inc.
• 8.10 Morris & Dickson Co., LLC
• 8.11 Owens & Minor, Inc.
• 8.12 Patterson Companies, Inc.
• 8.13 Pheonix Group
• 8.14 Sinopharm Group
• 8.15 Suzuken Co., Ltd.